1. Antibodies
  2. Primary Antibodies
  3. Monoclonal Antibodies
  4. Myogenin Antibody (YA5691)

Myogenin Antibody (YA5691)

Cat. No.: HY-P85999
User Guide for Antibodies Technical Support

Myogenin Antibody (YA5691) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Myogenin.

For research use only. We do not sell to patients.

Size Stock
50 μL   Get quote  
100 μL   Get quote  

* Please select Quantity before adding items.

Top Publications Citing Use of Products

【WB: Western Blot; IHC-P: Immunohistochemistry-Paraffin; IHC-F: Immunohistochemistry-Frozen; ICC/IF: Immunocytochemistry/Immunofluorescence; IF-Tissue: Immunofluorescence-Tissue; mIHC: Multiplex Immunohistochemical; IP: Immunoprecipitation; ChIP: Chromatin Immunoprecipitation; FC: Flow Cytometry; ELISA: Enzyme Linked Immunosorbent Assay】

  • Biological Activity

  • Technical Parameters

  • Properties

  • Documentation

Description

Myogenin Antibody (YA5691) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Myogenin.

Background

Myogenin is a transcriptional activator that promotes the transcription of muscle-specific target genes and plays roles in muscle differentiation, cell cycle exit, and muscle atrophy. It is essential for the development of functional embryonic skeletal muscle fibers but dispensable for postnatal skeletal muscle growth. Phosphorylation by CAMK2G inhibits its transcriptional activity in response to muscle activity. Myogenin is required for recruiting the FACT complex to muscle-specific promoter regions to initiate gene expression. During terminal myoblast differentiation, it acts as a strong transcriptional activator at loci with open chromatin structures previously initiated by MYOD1. It co-occupies muscle-specific gene promoter core regions with MYF5 and MYOD1 during myogenesis and cooperates with the myocyte-specific enhancer factor MEF2D and BRG1-dependent recruitment of SWI/SNF chromatin-remodeling enzymes to alter chromatin structure at myogenic late gene promoters. By upregulating miR-20a expression, it facilitates cell cycle exit during terminal muscle differentiation, where miR-20a represses cell cycle progression genes. It binds to the E-box-containing (E1) promoter region of the miR-20a gene and prevents the reversal of muscle cell differentiation. Additionally, it contributes to atrophy-related gene expression in adult denervated muscles. By similarity, it also induces fibroblast differentiation into myoblasts.

Gene ID
SwissProt ID
Molecular Weight

Predicted band size: 25 kDa;

Purity

affinity chromatography.

Conjugation

Non-conjugated

Modification

Unmodified

Product Categories

Primary Antibody; Mouse Monoclonal Antibody

Clonality

Monoclonal

Host

Mouse

Reactivity

Human, Mouse, Rat

Dilution Ratio

IHC: 1:50-200; ICC/IF: 1:50-200; ELISA: 1:500-5000

Application

IHC-P, ICC/IF, ELISA

Appearance

Liquid

Formulation

Supplied in PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA

Storage & Stability

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

Shipping

Shipping with blue ice.

Isotype

IgG1

Immunogen

Synthesized peptide derived from human Myogenin AA range: 100-200

Documentation

Myogenin Antibody (YA5691) Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Myogenin Antibody (YA5691)
Cat. No.:
HY-P85999
Quantity:
MCE Japan Authorized Agent: